Ultragenyx Pharmaceutical Inc. buy Guggenheim
Start price
20.06.25
/
50%
€32.00
Target price
20.06.26
€55.59
Performance (%)
-37.56%
Price
05.06.26
€19.98
Summary
This prediction is currently active. The BUY prediction by Guggenheim for Ultragenyx Pharmaceutical Inc. is performing very badly with a performance of -37.56%. This prediction currently runs until 20.06.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -1.818% | -1.818% |
| iShares Core DAX® | -1,86 % | 0,67 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % |
| iShares S&P 500 | -1,31 % | 3,40 % |
Comments by Guggenheim for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $64.00 price target on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Guggenheim for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€22.10
08.05.26
08.05.26
€36.67
08.05.27
08.05.27
-10.11%
05.06.26
05.06.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€20.00
05.01.26
05.01.26
€44.47
05.01.27
05.01.27
-4.93%
05.06.26
05.06.26